Previous studies have shown that miR-125b suppresses NF-κB activation through direct targeting of TRAF6 in sepsis [35] and promotes inflammation via A20 inhibition in rheumatoid arthritis [20]. Here, NFKB1 is linked to rheumatoid arthritis.